The Role Of Nitazoxanide, Interferon Alfa And Ribavirin In Treatment Of Hepatitis C Infected Type 2 Diabetic Patients
Status:
Completed
Trial end date:
2013-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if nitazoxanide used in combination with
interferon alfa and ribavirin is effective in treating Hepatitis c infected type 2 Diabetic
patients by improving their sustained viral response by more than 80%.Considering that the
study is being conducted in a third world country like Pakistan, the standard treatment of
hepatitis C is not cost effective. The aim is to introduce a new treatment comparable in
efficacy to peginterferon and also cost effective.